#cannabisaficionado

Cannabis

Colorado Cannabis Safety Audit Calls for Stronger Oversight

A Colorado audit calls for improvements to cannabis oversight, while finding no evidence supporting claims of widespread product safety problems.

Published

on

Blue-gloved hand holding a glass beaker of clear liquid in a laboratory
Advertisement Back2Grow Advertisement

A new Colorado audit raises a question that goes beyond whether cannabis has passed a laboratory test: how well can the state independently check that the system is working?

The Marijuana Consumer Safety performance audit, released October 19, identifies weaknesses in regulatory oversight and testing support. It also makes a crucial distinction: auditors found no evidence supporting claims of widespread health and safety problems in regulated marijuana products.

Where the audit sees gaps

The report describes limits in state reference laboratory capacity, inconsistent monitoring and weaknesses in how potential problems are investigated and communicated. These findings concern the safeguards around the market; they do not amount to a finding that every product is unsafe.

One example is independent testing capacity. As of May 15, 2026, the state reference laboratory could not test for pesticides, residual solvents or mycotoxins—tests required for marijuana products sold in Colorado. That limitation concerns the state laboratory’s ability to support oversight, not the absence of those requirements for commercial products.

Why independent checks matter

For readers comparing flower, concentrates or edibles, a test result and the system supervising that result answer related but different questions. Product testing examines a sample. Oversight asks whether the sampling, methods and follow-up can be trusted across the market.

The audit made 14 recommendations, and the agencies agreed with all 14. Agreement marks the beginning of the response; it does not establish that the recommended improvements are already complete.

The useful takeaway is to read the findings at their actual scope. This is a call to strengthen Colorado’s safety framework, not a blanket warning against every regulated product or a product-specific recall.

Related reading: Why independent cannabis testing matters.

Laboratory equipment in use. Illustrative stock photograph; not a Colorado cannabis testing facility. Photo: RephiLe water / Unsplash.

Cannabis

New York Opens Cannabis Nursery Applications November 5

New York’s first nursery application window opens November 5, with an initial review of 50 applications for businesses supplying seeds and young plants.

Published

on

New York is opening a new door for the businesses behind the plants. Its first adult-use cannabis nursery application window begins November 5, 2026, creating a dedicated licensing route for suppliers of seeds, clones and immature plants.

The immediate opportunity is for businesses supplying licensed growers. A nursery license alone will not allow direct sales to consumers or home growers, according to the Office of Cannabis Management’s guidance.

A small first round, with more to follow

The Cannabis Control Board approved the window on October 1. OCM will consider the first 50 applications received, reviewing them in submission order once that target is reached. Applications beyond the initial 50 will not be considered in this round, and those applicants’ fees will be returned.

That number describes the opening round, rather than a permanent statewide ceiling. In an October 21 analysis, Vicente LLP’s Bridgette Nikisher and Brandon Kurtzman explain that the staged approach is intended to manage the rollout. Additional application windows are planned.

What prospective nursery operators should prepare

OCM lists a $1,000 application fee, with separate license fees based on outdoor, mixed-light or indoor cultivation. Qualified social and economic equity applicants can receive a 50% reduction in application and license fees.

Vicente’s application overview highlights several preparations: a Nursery Grower Certificate of Registration, proof of control over the proposed location, a labor peace agreement and business ownership information. Applications will go through New York Business Express.

For cannabis enthusiasts, the distinction matters: this is an upstream supply development, not the opening of a new home-grow shop. It puts the focus on how licensed growers obtain their starting material—the part of a cultivation story that begins before the flower reaches a dispensary shelf.

Related reading: How California’s growing footprint shapes its harvest.

A young cannabis plant. Illustrative stock photograph; not a New York licensed nursery. Photo: Colin redwood / Unsplash.

Continue Reading

Cannabis

Kentucky’s Medical Cannabis Network Reaches 26 Open Dispensaries

Kentucky now lists 26 operating medical cannabis dispensaries, as Governor Andy Beshear reports 46 of 80 approved businesses are up and running.

Published

on

Glass jars of dried cannabis flower arranged on a retail counter

Kentucky’s medical cannabis market is becoming easier to find on a map. The state’s October 16 directory lists 26 operating dispensaries, while Governor Andy Beshear’s latest update puts the wider business rollout past its halfway point.

Beshear said on October 21 that 46 of 80 approved cannabis businesses were operating, according to Tom Angell’s reporting for Marijuana Moment. That total includes 13 cultivators, two safety compliance facilities, five processors and 26 dispensaries.

Open doors matter more than licenses alone

The figures describe a supply chain taking shape, rather than 46 places where patients can shop. Cultivators, processors and testing facilities perform different roles from dispensaries; combining them into one number can make access sound broader than the retail footprint alone.

Kentucky’s official dispensary directory separates operating locations from the larger set of licensed businesses. Its October 16 update includes Sunnyside Prestonsburg, open since October 13, and a Lexington location operated by DHK KY LLC, open since October 16.

The directory warns that some licensed dispensaries are not yet operating and that locations can change. For someone planning a visit, the operational list is a more useful starting point than a license announcement. Checking the retailer’s current hours before traveling is a sensible next step.

A growing network, with work still ahead

Beshear also cited more than 29,000 people approved for medical cannabis cards and more than 500 registered practitioners, Marijuana Moment reported. Those are the governor’s figures, not an independent measure of patient satisfaction or product availability.

Kentucky’s medical cannabis program took legal effect January 1, 2025. Its website provides practitioner searches, card application information and patient education sessions. As the network expands, those practical resources help turn a statewide milestone into a clearer path for individual patients.

Cannabis flower displayed in glass jars. Illustrative stock photograph; not a Kentucky dispensary. Photo: Cova Software / Unsplash.

Continue Reading

Cannabis

New Jersey Hemp Drink Extension and Retail Penalties Advance

Two New Jersey bills would adjust the hemp beverage deadline and strengthen penalties for unlicensed cannabis sales. Neither is law yet.

Published

on

Unbranded yellow beverage cans with silver pull tabs

Illustrative stock photograph of beverage cans; these are not identified as THC products. Photo by YesMore Content on Unsplash.

New Jersey lawmakers are pursuing two changes that could reshape the cannabis retail landscape: more time for certain hemp beverage sales and tougher penalties for businesses selling cannabis without a license.

The Senate Judiciary Committee advanced both measures on October 15. As of October 22, the Legislature lists S4635, the hemp measure, at second reading in the Senate. The enforcement proposal, S4287, has been referred to the Senate Budget and Appropriations Committee. Neither listing shows an enacted law.

A deadline that would follow federal law

S4635 would align state restrictions on hemp products and intoxicating hemp beverages with the effective dates of federal changes. Its Assembly counterpart is A5604.

An October 15 Assembly committee statement explains that a September federal funding measure partially delayed the relevant changes until December 11, 2026. The proposal is designed to accommodate further federal timing changes, rather than simply replace one fixed date with another.

That distinction matters for shops planning inventory. New Jersey’s existing Chapter 13 law allows specified alcohol and cannabis license holders to sell intoxicating hemp beverages until November 13. A bill moving through committee does not itself change that deadline.

A separate push on unlicensed sales

In October 19 reporting for Cannabis Business Times, Tony Lange explains that S4287 would make certain unlicensed commercial cannabis sales a third-degree crime. Proposed fines range from $10,000 to $50,000 for covered individuals and $100,000 to $250,000 for covered business entities.

The measures address different questions: how long qualifying hemp products can remain in existing sales channels, and what happens when businesses sell outside the licensing system. For shoppers, the next meaningful development is passage and enactment—not simply a committee vote. For now, these are proposals to watch, not new permissions for retailers.

Related reading: Delaware’s approach to THC beverage rules.

Continue Reading

Trending

Join The Cannabis Aficionado Community!
Join the Cannabis Aficionado community and receive all of the most relevant news geared towards our sophisticated enthusiast community.
Loading

Copyright ©️ 2026 Cannabis Aficionado. Cannabis Aficionado is a registered trademark of CNM Inc. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service, Privacy Policy and Cookies Policy. People may receive compensation for some links to products and services. Offers may be subject to change without notice.